A crash course in IP strategy

"Publish, publish, publish!" Sound familiar? So to meet the researcher's wishes, do you scribble a patent application with lipstick on a napkin and send it in? At the seminar Patent Strategies in the Biotech Company, you will have the chance to find out why this might not be the best idea.

BMAs: Run your own business

After graduation you must decide: be an employee or start your own business. This is not really the situation for BMAs today, but a collaborative project between Swedish public actors and some companies aims to change that and make entrepreneurs of BMAs.

300 miljoner tar Karolinska Development till börsen

Karolinska Development genomför en nyemission på 300 miljoner som vänder sig till både existerande och nya utländska investerare. Målet är en ägarspridning inför en börsintroduktion som kan ske redan till våren.

Young, bright and committed to labtech

Ghazal Voghoui recently bought her first apartment and finally settled in Stockholm again. Last year, she finished her law studies and she is relieved to be back after living in Geneva for four years. On November 10 she will take a big career leap

Reidar Rasmussen, Labmodul

Why are you going to Scanlab and Biotech Forum?

How to get the most out of the fair

Life science in Stockholm

Sweden has the fourth-largest biotech market in Europe. More than half of its biotechnology enterprise, some 460 companies, is located in the Stockholm region.

Cate Poulsen, Qiagen

Why are you going to Scanlab and Biotech Forum?

From planning stage to handshake

"Partnering is an effective tool to get in touch with the decision makers high up in an organization's administration," says Camilla Huse Bondeson at Conlega. And according to her, rigorous planning is the way to succeed.

Nordiska pipelinen är torr

Endast 15 läkemedelskandidater anses enligt en EU-rapport ha någon ny target på multiresistenta bakterier. En restriktiv hållning att använda nya antibiotika gör att marknaden för utvecklingen är obefintlig. Ingen av läkemedelskandidaterna i rapporten är nordiska. (Uppdaterad).

Heltäckande serie av mikroplattor

BRANDplates är en serie mikroplattor från Brandtech Scientific Inc som täcker in alla typer av mikroplattor och kan användas för applikationer inom immunologi och cellodling.

Nytt namn i Symphogens ledning

Adriann Sax har utsetts till affärschef på det danska företaget.

The winner of the race

She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is focus according to Yvonne Mårtensson.

With their hands on the legal levers

It is wonderful news for the Scandinavian scientific community. At the end of May it stood clear that Lund will host to the European Spallation Source.

Han ger råd till Gothia Forum

Det nya samarbetet kring kliniska studier i väst har fått en ordförande till sin advisory board.

Kattforskare får pris

Jonas Wensman belönas för sin forskning kring en neurologisk sjukdom som främst drabbar utekatter.

Ny ledare till sött bolag

Han ska leda Daniscos affärsområde för sötningsmedel.

Instrument för skräddarsydd behandling snart här

En apparat stor som en mobiltelefon kan komma att revolutionera förskrivningen av läkemedel.

Major changes to the Q-Med board

The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.

Faster sales but less profits for Probi

The probiotic company increases its turnover, and the net results are twice as large as last year.

Pfizer lays a chunky bid on Wyeth

The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at approximately $68 billion. The Boards of Directors of both companies have said yes to the deal

Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.

Success fee to Bioinvent and partner

The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.

New member to Active board

The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be re-elected at the AGM in May.